Boulder, CO, United States of America

David L Snitman


 

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 456(Granted Patents)


Company Filing History:


Years Active: 1983-2007

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: David L. Snitman: A Pioneer in Genetic Engineering

Introduction

David L. Snitman, based in Boulder, Colorado, is a distinguished inventor with a remarkable portfolio of 14 patents. His contributions to the field of genetic engineering have significantly advanced the understanding and capabilities of biologically active proteins, particularly human immune and leukocyte interferons.

Latest Patents

One of his latest patents focuses on the manufacture and expression of large structural genes. This innovation details the preparation and expression of engineered genes that can direct the synthesis of human immune and leukocyte interferons and other biologically active proteins. These products are designed to differ from naturally occurring forms in terms of amino acid identity or position and various biological and pharmacological properties, while still retaining essential functionalities. This work is crucial in the realm of biotechnology, particularly for therapeutic applications.

Career Highlights

Throughout his career, David has worked with several prestigious companies, including E.R. Squibb & Sons, Inc. and Amgen Inc., where he has played a vital role in research and development. His expertise in the field has positioned him as a key contributor to advancements in genetic engineering and biopharmaceuticals.

Collaborations

David collaborated with notable figures in the industry, such as Martin F. Haslanger and Peter W. Sprague. These partnerships have enriched his research endeavors and expanded the scope of his innovations, contributing significantly to the scientific community's understanding of complex genetic mechanisms.

Conclusion

David L. Snitman’s innovative work in the manufacture and expression of large structural genes underscores his importance in the field of genetic engineering. With a commendable number of patents and a career marked by significant collaborations, he continues to influence the landscape of biotechnology and medical research. His efforts pave the way for new treatments and understanding in the biologically active protein sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…